XML 23 R7.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) (USD $)
In Thousands, unless otherwise specified
6 Months Ended
Jun. 30, 2014
Jun. 30, 2013
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net earnings $ 428,132 $ 435,280
Provision for losses on accounts receivable 4,782 3,783
Deferred income taxes and tax uncertainties (9,605) (1,074)
Depreciation and amortization 93,796 80,813
Losses (gains) from sales of assets and write-offs 14,576 (868)
Stock-based compensation 28,988 31,372
Change in operating assets and liabilities - net of business acquisitions and divestitures:    
Accounts receivable (98,574) (155,887)
Inventories (13,497) 57,771
Prepaid expenses and other assets (4,610) 31,369
Trade accounts payable 2,852 31,472
Other current liabilities (127,930) (128,468)
Current income taxes payable 1,601 (2,648)
Employment-related and other non-current liabilities 6,712 8,088
Other - net 1,243 (4,180)
Net cash provided by operating activities 328,466 386,823
CASH FLOWS FROM INVESTING ACTIVITIES:    
Additions to property, buildings and equipment (156,210) (83,175)
Proceeds from sales of property, buildings and equipment 5,416 2,528
Net cash received (paid) for business divestitures (acquisitions) 19,199 (8,234)
Other - net 0 100
Net cash used in investing activities (131,595) (88,781)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Borrowings under lines of credit 44,686 105,412
Payments against lines of credit (64,634) (114,436)
Net borrowings of commercial paper 54,997 0
Net decrease in long-term debt (9,538) (4,845)
Proceeds from stock options exercised 31,816 48,142
Excess tax benefits from stock-based compensation 22,177 41,690
Purchase of treasury stock (235,847) (202,400)
Cash dividends paid (140,885) (123,549)
Net cash used in financing activities (297,228) (249,986)
Exchange rate effect on cash and cash equivalents 1,420 (11,378)
NET CHANGE IN CASH AND CASH EQUIVALENTS (98,937) 36,678
Cash and cash equivalents at beginning of period 430,644 452,063
Cash and cash equivalents at end of period $ 331,707 $ 488,741